Association between FABP2 Ala54Thr polymorphisms and type 2 diabetes mellitus risk: A HuGE Review and Meta-Analysis

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 12, 2014, Pages 2530-2535

  Qiu, Chun Jian ^a   Ye, Xiao Zheng ^b   Yu, Xiao Juan ^a   Peng, Xiao Ren ^a   Li, Tong Huan ^a  

^a No 81 Hospital of PLA   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Diabetes mellitus, type 2; Fatty acid binding protein 2; Meta analysis; Single nucleotide polymorphism; Susceptibility

Indexed keywords

FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ODDS RATIO; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACID-BINDING PROTEINS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MUTATION, MISSENSE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84911413677     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12385     Document Type: Article

References (35)

1. Gulliford MC, Charlton J. Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol. 2009; 169: 455-61.
2. International Diabetes Federation. Available at: http://www.diabetesatlas.org/content/diabetes (accessed 10 February 2012).
3. Lin JD, Hsia TL, Wu CZ, et al. The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus. Metabolism. 2010; 59: 780-6.
4. Vimaleswaran KS, Loos RJ. Progress in the genetics of common obesity and type 2 diabetes. Expert Rev Mol Med. 2010; 12: e7.
5. Sweetser DA, Birkenmeier EH, Klisak IJ, et al. The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem. 1987; 262: 16060-71.
6. Hertzel AV, Bernlohr DA. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab. 2000; 11: 175-80.
7. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008; 7: 489-503.
8. Baier LJ, Sacchettini JC, Knowler WC, et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest. 1995; 95: 1281-7.
9. Agren JJ, Vidgren HM, Valve RS, et al. Postprandial response of individual fatty acids in subjects homozygous for the threonine or alanine encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr. 2001; 73: 31-5.
10. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954; 10: 101-29.
11. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22: 719-48.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-88.
13. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999; 8: 15-7.
14. Egger M, Davey Smith G, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997; 315: 629-34.
15. Alharbi KK, Khan IA, Bazzi MD, et al. A54T polymorphism in the fatty acid binding protein 2 studies in a Saudi population with type 2 diabetes mellitus. Lipids Health Dis. 2014; 13: 61.
16. Raza ST, Fatima J, Ahmed F, et al. Association of angiotensin-converting enzyme (ACE) and fatty acid binding protein 2 (FABP2) genes polymorphism with type 2 diabetes mellitus in Northern India. J Renin Angiotensin Aldosterone Syst. 2013; Mar 6. [Epub ahead of print].
17. Shi Q, Yan F, Wang X, et al. Association between polymorphism of the fatty acid-binding protein 2 gene and type 2 diabetes. Chin J Med Guide. 2012; 14: 930-3.
18. Bu L, Salto LM, De Leon KJ, et al. Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes. Diabetes Res Clin Pract. 2011; 92: 82-91.
19. Tavridou A, Arvanitidis KI, Tiptiri-Kourpeti A, et al. Thr54 allele of fatty-acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population. Diabetes Res Clin Pract. 2009; 84: 132-7.
20. Albala C, Villarroel A, Santos JL, et al. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res Clin Pract. 2007; 77: 245-50.
21. Li Y, Fisher E, Klapper M, et al. Association between functional FABP2 promoter haplotype and type 2 diabetes. Horm Metab Res. 2006; 38: 300-7.
22. Guettier JM, Georgopoulos A, Tsai MY, et al. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab. 2005; 90: 1705-11.
23. Duarte NL, Colagiuri S, Palu T, et al. Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Mol Genet Metab. 2003; 79: 183-8.
24. Wang G, Li Q, Hong T, et al. Association between fatty acid-binding protein 2 gene and type 2 diabetes. Clin Genet Res. 2001; 14: 447-8.
25. Boullu-Sanchis S, Leprêtre F, Hedelin G, et al. Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. Diabetes Metab. 1999; 25: 150-6.
26. Ito K, Nakatani K, Fujii M, et al. Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population. Diabet Med. 1999; 16: 119-24.
27. Rissanen J, Pihlajamäki J, Heikkinen S, et al. The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects. Diabetes. 1997; 46: 711-2.
28. Weiss EP, Brown MD, Shuldiner AR, et al. Fatty acid binding protein-2 gene variants an insulin resistance: gene and gene-environment interaction effects. Physiol Genomics. 2002; 10: 145-57.
29. Rodriguez C, Calle EE, Miracle-McMahill HL, et al. Family history and risk of fatal prostate cancer. Epidemiology. 1997; 8: 653-9.
30. Mitchell BD, Kammerer CM, O'Connell P, et al. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes. 1995; 44: 1046-53.
31. Albala C, Santos JL, Cifuentes M, et al. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res. 2004; 12: 340-5.
32. Kim CH, Yun SK, Byun DW, et al. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men. Metabolism. 2001; 50: 473-6.
33. Yamada K, Yuan X, Ishiyama S, et al. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia. 1997; 40: 706-10.
34. de Luis DA, Aller R, Izaola O, et al. Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects. Ann Nutr Metab. 2006; 50: 354-60.
35. Zhao T, Zhao J, Yang W. Association of the fatty acid-binding protein 2 gene Ala54Thr polymorphism with insulin resistance and blood glucose: a meta-analysis in 13451 subjects. Diabetes Metab Res Rev. 2010; 26: 357-64.